| Lastest Insider Transactions Of Keros Therapeutics, Inc. ( KROS ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| KROS | Keros Therapeutics, Inc. | BIENAIME JEAN JACQUES | Directior | 2026-03-09 | Buy | 2,000 | 11.21 | 22,420 | 2026-03-11 16:33:59 |
| KROS | Keros Therapeutics, Inc. | Seehra Jasbir | CHIEF EXECUTIVE OFFICER | 2026-02-19 | Sell | 7,015 | 16.17 | 113,433 | 2026-02-20 16:15:17 |
| KROS | Keros Therapeutics, Inc. | Lerner Lorena Raquel | Chief Science Officer | 2026-02-18 | Sell | 3,873 | 16.35 | 63,324 | 2026-02-20 16:15:14 |
| KROS | Keros Therapeutics, Inc. | Cho Esther | SVP, General Counsel | 2026-02-18 | Sell | 4,745 | 16.35 | 77,581 | 2026-02-20 16:15:11 |
| KROS | Keros Therapeutics, Inc. | Regnante Keith | CHIEF FINANCIAL OFFICER | 2026-02-18 | Sell | 4,739 | 16.35 | 77,483 | 2026-02-20 16:15:07 |
| KROS | Keros Therapeutics, Inc. | Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | 2025-10-15 | Sell | 4,787,331 | 17.75 | 84,975,128 | 2025-10-17 17:53:28 |
| KROS | Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC | 10% Owner | 2025-10-15 | Sell | 5,389,264 | 17.75 | 95,659,440 | 2025-10-15 13:24:20 |
| KROS | Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC | 10% Owner | 2025-10-15 | Sell | 5,389,264 | 17.75 | 95,659,440 | 2025-10-15 13:24:20 |
| KROS | Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC | 10% Owner | 2025-04-09 | Buy | 934,258 | 10.13 | 9,464,512 | 2025-04-11 21:57:19 |
| KROS | Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC | 10% Owner | 2025-04-09 | Buy | 934,258 | 10.13 | 9,464,512 | 2025-04-11 21:57:19 |
| KROS | Keros Therapeutics, Inc. | Seehra Jasbir | CHIEF EXECUTIVE OFFICER | 2025-04-04 | Option Exercise | 49,367 | 0.30 | 14,810 | 2025-04-07 16:15:07 |
| KROS | Keros Therapeutics, Inc. | Regnante Keith | CHIEF FINANCIAL OFFICER | 2024-01-04 | Sell | 40,000 | 45.29 | 1,811,600 | 2025-01-24 16:15:08 |
| KROS | Keros Therapeutics, Inc. | Regnante Keith | CHIEF FINANCIAL OFFICER | 2024-01-04 | Option Exercise | 40,000 | 16.00 | 640,000 | 2025-01-24 16:15:08 |
| KROS | Keros Therapeutics, Inc. | GORDON CARL L | Directior | 2024-08-13 | Sell | 250,000 | 44.01 | 11,002,500 | 2024-08-15 17:06:51 |
| KROS | Keros Therapeutics, Inc. | ORBIMED ADVISORS LLC | Directior | 2024-08-13 | Sell | 250,000 | 44.01 | 11,002,500 | 2024-08-15 17:01:28 |
| KROS | Keros Therapeutics, Inc. | Regnante Keith | Chief Financial Officer | 2023-11-04 | Sell | 40,000 | 45.29 | 1,811,600 | 2024-01-08 16:43:46 |
| KROS | Keros Therapeutics, Inc. | Regnante Keith | Chief Financial Officer | 2023-11-04 | Option Exercise | 40,000 | 16.00 | 640,000 | 2024-01-08 16:43:46 |
| KROS | Keros Therapeutics, Inc. | Regnante Keith | Chief Financial Officer | 2023-06-08 | Sell | 40,000 | 46.61 | 1,864,239 | 2023-06-12 16:13:40 |
| KROS | Keros Therapeutics, Inc. | Regnante Keith | Chief Financial Officer | 2023-06-08 | Option Exercise | 40,000 | 16.00 | 640,000 | 2023-06-12 16:13:40 |
| KROS | Keros Therapeutics, Inc. | Seehra Jasbir | Chief Executive Officer | 2023-04-08 | Option Exercise | 4,000 | 0.48 | 1,920 | 2023-04-11 16:05:25 |
| KROS | Keros Therapeutics, Inc. | Knowles Julius | Directior | 2020-04-13 | Buy | 1,191 | 20.98 | 24,987 | 2023-01-20 16:32:18 |
